Garlic for diabetes mellitus

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 7, 2016, Pages

  Ge, Long ^a   Li, Lun ^b   Tian, Jin Hui ^a   Yang, Kehu ^a  

^a LANZHOU UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; DIABETES MELLITUS; GARLIC; INTERVENTION STUDY; PRIORITY JOURNAL; PUBLICATION; REVIEW; SYSTEMATIC REVIEW;

EID: 84978646298     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009981.pub2     Document Type: Review

References (31)

1. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors. Archives of Internal Medicine 2001;161(6):813-24. [PUBMED: 11268223 ]
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999;22(Suppl 1):S5-19.
3. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 2008;31(Suppl 1):S12-54. [PUBMED: 18165335]
4. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011;34(Suppl 1):S62-9. [PUBMED: 21193628]
5. Al-Qattan KK, Thomson M, Ali M, Mansour MH. Garlic (Allium sativum) attenuate glomerular glycation in streptozotocin-induced diabetic rats: A possible role of insulin. Pathophysiology 2013;20(2):147-52.
6. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: a review. Nutrition Journal 2002;1(1):4. [DOI: 10.1186/1475-2891-1-4/journal.pmed.12537594]
7. Beller EM, Chen JK, Wang UL, Glasziou PP. Are systematic reviews up-to-date at the time of publication?. Systematic Reviews 2013;2(1):36. [2046-4053: (Electronic)]
8. Colagiuri R. Diabetes: a pandemic, a development issue or both?. Expert Review of Cardiovascular Therapy 2010;8(3):305-9. [DOI: 10.1586/erc.10.12/journal.pmed.20222807]
9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993;329(14):977-86. [PUBMED: 8366922]
10. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6.
11. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58. [PUBMED: 10.1002/sim.1186/journal.pmed.12111919]
12. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-60. [10.1136/bmj.327.7414.557./journal.pmed.12958120]
13. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
14. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
15. Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. Canadian Medical Association Journal 2013;185(4):E201-11.
16. International Diabetes Federation. World Diabetes Media Kit: every 10 seconds 1 person dies of diabetes. International Diabetes Federation, Brussels, Belgium, 2007. www.idf.org/webdata/docs/World_Diabetes_Day_Media_Kit.pdf (accessed 21 May 2012).
17. International Diabetes Federation. Diabetes data - IDF diabetes atlas 4th edition, 2009.. http://www.idf.org/media/press-materials/diabetes-data (accessed 21 May 2012).
18. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365. [DOI: 10.1136/bmj.c365]
19. Kook S, Kim GH, Choi K. The antidiabetic effect of onion and garlic in experimental diabetic rats: meta-analysis. J Med Food 2009;12(3):552-60.
20. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine 2009;6(7):1-28. [DOI: 10.1371/journal.pmed.1000100]
21. Liu CT, Sheen LY, Lii CK. Does garlic have a role as an antidiabetic agent?. Molecular Nutrition & Food Research 2007;51(11):1353-64. [DOI: 10.1002/mnfr.200700082/journal.pmed.17918164]
22. Meader N, King K, Llewellyn A, Norman G, Brown J, Rodgers M, et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Syst Rev 2014;3:82.
23. Meher S, Duley L. Garlic for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD006065]
24. Noknoy S, Chamnan P, Anothaisintawee T. Theory-based behavioural interventions for prediabetic state and people with diabetes mellitus. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD008082]
25. Padiya R, Khatua TN, Bagul PK, Kuncha M, Banerjee SK. Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats. Nutr Metab (Lond) 2011;8(53):1-8.
26. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ 2011;342:d549.
27. Rivlin RS. Historical perspective on the use of garlic. Journal of Nutrition 2001;131(Suppl 3):951-4. [PUBMED: 11238795]
28. Sierra G. The global pandemic of diabetes. African Journal of Diabetes Medicine 2009;17:4-8.
29. Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
30. Alberti KM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 1998;15:539-53.
31. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336(7644):601-5.